Two cases of adult Still's disease with abnormally high level of telomerase activity in peripheral blood mononuclear cells

Modern Rheumatology

Volumn 14, Issue 5, 2004, Pages 394-398

  Kurosaka, Daitaro ^a   Yasuda, Jun ^a   Kingetsu, Isamu ^a   Yasuda, Chiho ^a   Yoshida, Ken ^a   Toyokawa, Yasuhiko ^a   Yokoyama, Toru ^a   Yamada, Akio ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adult Still's disease; Peripheral blood mononuclear cells (PBMCs); Telomerase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; FERRITIN; PREDNISOLONE; STEROID; TELOMERASE;

ADULT ONSET STILL DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; ENZYME ACTIVITY; ERYTHEMA; FEMALE; FERRITIN BLOOD LEVEL; FEVER; HUMAN; MALAISE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; STEROID THERAPY;

EID: 8444231987     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-004-0329-y     Document Type: Article

References (21)

1. Zakian VA. Telomeres: Beginning to understand the end. Science 1995;270:1601-7.
2. Counter CM. The roles of telomeres and telomerase in cell life span. Mutat Res 1996;366:45-63.
3. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-91.
4. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-5.
5. Rus V, Via CS. Telomeres, telomerase, and lupus: The long and short of it. Clin Immunol 2001;99:195-7.
6. Kurosaka D, Ozawa Y, Yasuda J, Yokoyama T, Yamada A, Akiyama M, et al. Telomerase activity in peripheral blood mononuclear cells from patients with SLE. Ann Rheum Dis 2001;60:1158-9.
7. Kurosaka D, Yasuda J, Yoshida K, Yokoyama T, Ozawa Y, Obayashi Y, et al. Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients. Lupus 2003; 12:591-9.
8. Katayama Y, Kohriyama K. Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases. J Rheumatol 2001;28:288-91.
9. Yudoh K, Matsuno H, Nezuka T, Kimura T. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: The role of telomerase activity in synovial proliferation. Arthritis Rheum 1999;42:669-77.
10. Yoshida K, Sugino T, Goodison S, Warren BF, Nolan D, Wadsworth S, et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer 1997;75:548-53.
11. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995;55:2734-6.
12. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996;106:759-65.
13. Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 1997;57:326-31.
14. Yashima K, Vuitch F, Gazdar AF, Fahey TJ. Telomerase activity in benign and malignant thyroid disease. Surgery 1997;122:1141-6.
15. Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Ando K, et al. Telomerase activity in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst 1998;90:684-90.
16. Hiyama K, Ishioka S, Shay JW, Taooka Y, Maeda A, Isobe T, et al. Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases. Int J Mol Med 1998;1:545-9.
17. Trentin L, Ballon G, Ometto L, Perin A, Basso U, Chieco-Bianchi L, et al. Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage. Br J Haematol 1999;106:662-8.
18. Kurosaka D, Yasuda J, Yasuda C, Yoshida K, Kingetsu I, Yokoyama T, et al. Telomerase activity of peripheral lymphoid cells in SLE patients. Ryumachi 2003;43:344 (in Japanese).
19. Koeller M, Kiener H, Simonitsch I, Aringer M, Steiner CW, Machold K, et al. Destructive lymphadenopathy and T-lymphocyte activation in adult-onset Still's disease. Br J Rheumatol 1995;34: 984-8.
20. Matsui K, Tsuchida T, Hiroishi K, Tominaga K, Hayashi N, Hada T, et al. High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease. Rheumatology (Oxford) 1999;38:477-8.
21. Bodnar AG, Kim NW, Effros RB, Chiu CP. Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996; 228:58-64.